Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
Author: PAM BELLUCK
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}